Emerging role of protein S-nitrosylation in diabetes and diabetes-associated diseases
Archives of Biochemistry and Biophysics · 2026-07 · 781 · 110823
DOI: 10.1016/j.abb.2026.110823 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archives of Biochemistry and Biophysics, 2026-07. Verfasst von Mei Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Taizhou Affiliated Hospital of Nanjing University of Chinese Medicine, Taizhou, 225300, China. Hauptthemen laut MEDLINE: Nitric Oxide, Diabetes Mellitus, Type 2, Protein Processing, Post-Translational. Die Arbeit nennt 108 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangsu Commission of Health.
Themen: Diabetes mellitus
Abstract (Originalsprache)
The global obesity epidemic is worsening in many parts of the world, leading to a gradual increase in the occurrence of metabolic illnesses such as type 2 diabetes mellitus (T2DM) and cardiovascular disorders. Emerging evidence highlights protein S-nitrosylation as a critical regulatory mechanism in diabetes-associated disease. S-nitrosylation, a post-translational redox-based modification that refers to the formation of a covalent bond between nitric oxide and a cysteine residue's reduced thiol, adds an S-nitrosothiol group to substrate proteins. Several recent investigations have shown that dysregulated protein S-nitrosylation contributes significantly to the development of insulin resistance, mitochondrial dysfunction, oxidative stress, inflammation, and ER stress in a wide range of metabolic disorders. In this review, we will describe the dynamic change between protein S-nitrosylation and denitrosylation in the etiology of diabetes and diabetes-associated disease, as well as the levels of S-nitrosylation enzyme activity and modification proteins in these diseases. This will highlight the therapeutic potential of focusing on the enzyme's activity to modify the levels of protein S-nitrosylation, thereby improving our understanding of nitric oxide's function in redox signaling and metabolic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Taizhou Affiliated Hospital of Nanjing University of Chinese Medicine, Taizhou, 225300, China.
- Key Laboratory for Metabolic Diseases in Chinese Medicine, First College of Clinical Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
- Department of Endocrinology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, 225001, China. Electronic address: zwzhang@yzu.edu.cn.
- Key Laboratory for Metabolic Diseases in Chinese Medicine, First College of Clinical Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China. Electronic address: wbshang@njucm.edu.cn.
- Key Laboratory for Metabolic Diseases in Chinese Medicine, First College of Clinical Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China. Electronic address: fphlcollegesci@njucm.edu.cn.
Förderung
- National Natural Science Foundation of China
- Jiangsu Commission of Health
Zitieren
APA
Yu, M., He, J., Xu, M., Zhang, Z., Shang, W., & Fang, P. (2026). Emerging role of protein S-nitrosylation in diabetes and diabetes-associated diseases. Archives of Biochemistry and Biophysics, 781, 110823. https://doi.org/10.1016/j.abb.2026.110823
Vancouver
Yu M, He J, Xu M, Zhang Z, Shang W, Fang P. Emerging role of protein S-nitrosylation in diabetes and diabetes-associated diseases. Archives of Biochemistry and Biophysics. 2026;781:110823. doi:10.1016/j.abb.2026.110823
BibTeX
@article{Yu2026,
author = {Yu, Mei and He, Junbo and Xu, Mengfan and Zhang, Zhenwen and Shang, Wenbin and Fang, Penghua},
title = {Emerging role of protein S-nitrosylation in diabetes and diabetes-associated diseases},
journal = {Archives of Biochemistry and Biophysics},
year = {2026},
volume = {781},
pages = {110823},
doi = {10.1016/j.abb.2026.110823}
}
EUVIMED